Remed Co.Ltd (302550) — Cash Flow Reinvestment Rate

Latest as of March 2026: 10.00x

Remed Co.Ltd (302550) has a Cash Flow Reinvestment Rate of 10.00x as of March 2026, reinvesting ₩2.39 Billion (capex ₩88.33 Million plus investments ₩2.30 Billion) from operating cash flow of ₩238.69 Million. Check 302550 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

10.00x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.39 Billion
Capex + Investments

Operating Cash Flow

₩238.69 Million
KRW

Capital Expenditures

₩88.33 Million
KRW

Remed Co.Ltd Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for Remed Co.Ltd across 7 annual periods. Explore 302550 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Remed Co.Ltd (2017–2025)

Year-by-year capital reinvestment analysis for Remed Co.Ltd. For live market cap and broader valuation context, see Remed Co.Ltd market cap and net worth.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 2.67x ₩6.41 Billion ₩2.40 Billion ₩868.76 Million ▼ -53.0%
2024 5.69x ₩7.08 Billion ₩1.24 Billion ₩608.80 Million ▼ -9.3%
2023 6.27x ₩21.95 Billion ₩3.50 Billion ₩893.97 Million ▲ +531.3%
2022 0.99x ₩5.18 Billion ₩5.21 Billion ₩4.77 Billion ▼ -92.6%
2020 13.44x ₩34.81 Billion ₩2.59 Billion ₩679.62 Million ▲ +740.3%
2019 1.60x ₩5.15 Billion ₩3.22 Billion ₩2.01 Billion ▼ -86.1%
2017 11.52x ₩768.89 Million ₩66.75 Million ₩768.89 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow